EUVIMEDEUVIMED entdecken
Open Access

An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection

Yan Sun, Kaixi Zhang, May Delos Santos, Carmen J E Pee, Yanmeng Yang, Meiqi Kang, Sung Jae Shin iD, Mary B Chan-Park, Kevin Pethe iD

Antimicrobial Agents and Chemotherapy · 07.08.2024 · 68 (8)

DOI: 10.1128/aac.01520-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 07.08.2024. Verfasst von Yan Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. Hauptthemen laut MEDLINE: Cyclophosphamide, Mycobacterium abscessus, Mycobacterium Infections, Nontuberculous, Disease Models, Animal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ministry of Education - Singapore (MOE), National Research Foundation Singapore (NRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium abscessus pulmonary infections are increasingly problematic, especially for immunocompromised individuals and those with underlying lung conditions. Currently, there is no reliable standardized treatment, underscoring the need for improved preclinical drug testing. We present a simplified immunosuppressed mouse model using only four injections of cyclophosphamide, which allows for sustained M. abscessus lung burden for up to 16 days. This model proved effective for antibiotic efficacy evaluation, as demonstrated with imipenem or amikacin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclophosphamideMycobacterium abscessusMycobacterium Infections, NontuberculousDisease Models, AnimalAnti-Bacterial AgentsAmikacinAnimalsMiceImipenemLungImmunocompromised HostFemale

Stichwörter der Autor:innen

M. abscessuslung infectionmouse model

Substanzen

CyclophosphamideAnti-Bacterial AgentsAmikacinImipenem

Autor:innen und Institutionen

  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Antimicrobial Resistance Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centre, Singapore, Singapore.
  • Interdisciplinary Graduate Programme, Nanyang Technological University, Singapore, Singapore.
  • Critical Analytics for Manufacturing of Personalized Medicine (CAMP) Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology Centre, Singapore, Singapore.
  • Department of Microbiology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, South Africa.
  • Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore, Singapore.

ORCID-Profile: Sung Jae Shin, Kevin Pethe

Förderung

  • Ministry of Education - Singapore (MOE)
  • National Research Foundation Singapore (NRF)

Zitieren

APA

Sun, Y., Zhang, K., Delos Santos, M., Pee, C. J. E., Yang, Y., Kang, M., Shin, S. J., Chan-Park, M. B., & Pethe, K. (2024). An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection. Antimicrobial Agents and Chemotherapy, 68(8). https://doi.org/10.1128/aac.01520-23

Vancouver

Sun Y, Zhang K, Delos Santos M, Pee CJE, Yang Y, Kang M, et al. An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection. Antimicrobial Agents and Chemotherapy. 2024;68(8). doi:10.1128/aac.01520-23

BibTeX
@article{Sun2024,
  author = {Sun, Yan and Zhang, Kaixi and Delos Santos, May and Pee, Carmen J E and Yang, Yanmeng and Kang, Meiqi and Shin, Sung Jae and Chan-Park, Mary B and Pethe, Kevin},
  title = {An optimized cyclophosphamide-treated mouse model of Mycobacterium abscessus pulmonary infection},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  volume = {68},
  number = {8},
  doi = {10.1128/aac.01520-23}
}
Kostenlos starten →